The ability to control PARylation reversal by PAR glycohydrolases48 particularly PARG, which is the predominant enzyme that removes PAR chains at sites of DNA damage12,49 offers the potential to control uniquely susceptible damage responses in cancer cells. Here, PARG is linked to cancer.